# Program 1 Synthetic Sandbox Implementation Track Phase J - Local Synthetic Demo Closure and No-UI Hold

Status: documentation/closure phase. Synthetic-only. Non-production. Local terminal-only. No real patient data. No PHI/PII. Not for clinical use.

## Purpose

Phase J closes the current local terminal-only synthetic sandbox demo after Phases A through I. It records that the sandbox is complete enough to pause and places the Program 1 Synthetic Sandbox Implementation Track into No-UI Hold.

Phase J is not a new feature phase, not a web UI phase, not a deployment phase, not production-readiness, not clinical validation, and not go-live authorization.

## Scope

- document local synthetic demo closure
- document No-UI Hold
- inventory current local terminal commands
- confirm safety boundaries
- record next-track decision options

## Non-Scope

Phase J does not add web UI, browser UI, server, API endpoint, network access, database access, integrations, file persistence, export files, EHR/EMR access, real-data ingestion, PHI/PII handling, patient messaging, appointment mutation, workflow enforcement, Task engine behavior, Outcome Evidence behavior, clinical write workflows, clinical writeback, autonomous diagnosis, autonomous treatment, triage execution, patient instruction delivery, clinician-facing executable recommendations, production-readiness claim, go-live authorization, approval/clearance/override capability, cloud deployment, deployment automation, new CLI command, or new runtime behavior.

## Phase A-I Completion Summary

| Phase | Summary | Current decision |
| --- | --- | --- |
| Phase A | Local synthetic patient workflow prototype | Completed for local synthetic sandbox use only |
| Phase B | Local sandbox usability loop | Completed for local synthetic sandbox use only |
| Phase C | Local clinician trial script and feedback capture | Completed for local synthetic design feedback only |
| Phase D | Local feedback review and iteration queue | Completed without clinical task creation |
| Phase E | Local clinician walkthrough pack | Completed for terminal walkthrough only |
| Phase F | Human-readable clinician walkthrough output | Completed for readable terminal output only |
| Phase G | Local interactive synthetic feedback input | Completed without persistence, export, or transmission |
| Phase H | Local synthetic session recap | Completed without clinical workflow behavior |
| Phase I | Local synthetic scenario comparison view | Completed without real patient comparison or clinical decision support |

Synthetic Sandbox Implementation Track A-I is complete enough to pause.

## Local Terminal Capability Inventory

The current allowed local terminal-only synthetic demo commands are:

- `python -m sandbox.program1.cli summary --scenario alpha`
- `python -m sandbox.program1.cli summary --scenario beta`
- `python -m sandbox.program1.cli trial --scenario alpha`
- `python -m sandbox.program1.cli trial --scenario beta`
- `python -m sandbox.program1.cli review-feedback`
- `python -m sandbox.program1.cli walkthrough`
- `python -m sandbox.program1.cli walkthrough --json`
- `python -m sandbox.program1.cli feedback-input --text "..."`
- `python -m sandbox.program1.cli feedback-input --text ""`
- `python -m sandbox.program1.cli feedback-input --text "..." --json`
- `python -m sandbox.program1.cli session-recap --scenario alpha`
- `python -m sandbox.program1.cli session-recap --scenario beta`
- `python -m sandbox.program1.cli session-recap --scenario alpha --feedback "..."`
- `python -m sandbox.program1.cli session-recap --scenario alpha --feedback "..." --json`
- `python -m sandbox.program1.cli compare-scenarios`
- `python -m sandbox.program1.cli compare-scenarios --json`

These commands are local terminal-only synthetic demo commands.

## No-UI Hold Record

- No web UI is authorized.
- No browser UI is authorized.
- No server/API is authorized.
- No local web app is authorized.
- No hosted preview is authorized.
- No deployment is authorized.
- No production mode is authorized.
- No EHR/EMR or clinic system integration is authorized.
- No database persistence is authorized.
- No export behavior is authorized.
- No patient-facing surface is authorized.
- No staff workflow surface is authorized.

## Safety Boundary Confirmation

The sandbox remains synthetic-only, non-production, local terminal-only, no real patient data, no PHI/PII, and not for clinical use.

The sandbox continues to prohibit network/database behavior, persistence/export, external integrations, EHR/EMR access, patient messaging, appointment mutation, workflow enforcement, clinical writeback, clinical task creation, autonomous diagnosis, autonomous treatment, patient instruction delivery, approval/clearance/override capability, production-readiness claim, and go-live authorization.

## Completion Checklist

- [x] terminal sandbox runs locally
- [x] alpha and beta scenarios exist
- [x] clinician-readable output exists
- [x] local feedback input exists
- [x] local session recap exists
- [x] local scenario comparison exists
- [x] JSON outputs preserve safety flags
- [x] default human-readable outputs avoid technical placeholder labels
- [x] no data is persisted or transmitted
- [x] no files are modified by running commands
- [x] no Phase K or later work is started

## Next-Track Decision Brief

After Phase J, any next direction must be explicitly authorized.

Potential options are:

- Stop and hold.
- Terminal polish only.
- UI Review Track, documentation-only, before any UI code.
- Local UI Prototype Track, only after explicit authorization and only synthetic/no-network/no-database if ever approved.

Do not start UI work automatically. Do not add web UI as a continuation of Phase J. Do not start production or integration work.

## Closure Statement

Phase J places the Program 1 Synthetic Sandbox Implementation Track into No-UI Hold. It is documentation-primary and does not add CLI behavior, runtime feature expansion, web UI, network/database/integration behavior, persistence/export, real data, PHI/PII, clinical workflow, patient messaging, appointment mutation, approval/override capability, go-live authorization, or Phase K work.
